TY - JOUR T1 - CorCast: A Distributed Architecture for Bayesian Epidemic Nowcasting and its Application to District-Level SARS-CoV-2 Infection Numbers in Germany JF - medRxiv DO - 10.1101/2021.06.02.21258209 SP - 2021.06.02.21258209 AU - Anna-Katharina Hildebrandt AU - Konstantin Bob AU - David Teschner AU - Thomas Kemmer AU - Jennifer Leclaire AU - Bertil Schmidt AU - Andreas Hildebrandt Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/02/2021.06.02.21258209.abstract N2 - Timely information on current infection numbers during an epidemic is of crucial importance for decision makers in politics, medicine, and businesses. As information about local infection risk can guide public policy as well as individual behavior, such as the wearing of personal protective equipment or voluntary social distancing, statistical models providing such insights should be transparent and reproducible as well as accurate. Fulfilling these requirements is drastically complicated by the large amounts of data generated during exponential growth of infection numbers, and by the complexity of common inference pipelines. Here, we present CorCast – a stable and scalable distributed architecture for the reproducible estimation of nowcasts suitable for pandemic scenarios – and its application to the inference of district-level SARS-CoV-2 infection numbers in Germany.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll source code for the deployment and operation of the CorCast system and for the district-level models for German infection numbers will be made available upon publication. https://github.com/hildebrandtlab/Covid19Nowcast.jl ER -